US-BLH BIO-ENGINEERING INT'L, INC.
CIK:0001547021|SEC Filings
|
Condensed Statements of Operations (Unaudited) (USD $)
|
3 Months Ended | 32 Months Ended | |
|---|---|---|---|
|
Mar. 31, 2013
|
Mar. 31, 2012
|
Mar. 31, 2013
|
|
| Income Statement [Abstract] | |||
| Revenue | |||
| Operating expenses | |||
| General and administrative | 1,225 | 14,122 | 67,031 |
| Total operating expenses | 1,225 | 14,122 | 67,031 |
| Loss from operations | (1,225) | (14,122) | (67,031) |
| Other expense | |||
| Interest expense | 100 | ||
| Total other expense | (100) | ||
| Income tax | (1,700) | ||
| Net loss | $ (1,225) | $ (14,122) | $ (68,831) |
| Basic and diluted loss per common share (in dollars per share) | $ 0.00 | $ 0.00 | |
| Weighted average shares outstanding (in shares) | 54,521,000 | 54,874,198 | |
|
Condensed Statements of Cash Flows (Unaudited) (USD $)
|
3 Months Ended | 32 Months Ended | |
|---|---|---|---|
|
Mar. 31, 2013
|
Mar. 31, 2012
|
Mar. 31, 2013
|
|
| Cash flows from operating activities | |||
| Net loss | $ (1,225) | $ (14,122) | $ (68,831) |
| Changes in operating liabilities: | |||
| Accounts payable | 95 | 2,500 | 3,446 |
| Net cash used in operating activities | (1,130) | (11,622) | (65,385) |
| Cash flows from investing activities | |||
| Cash flows from financing activities | |||
| Proceeds from related party loans | 1,130 | 2,836 | |
| Dividends paid | (19,232) | ||
| Proceeds from sale of stock | 82,500 | ||
| Cancellation of common shares | (719) | (719) | |
| Net cash provided by (used in) financing activities | 1,130 | (719) | 65,385 |
| Net change in cash | (12,341) | ||
| Cash at beginning of period | 18,346 | ||
| Cash at end of period | 6,005 | ||
| Supplemental cash flow information | |||
| Cash paid for interest | |||
| Cash paid for income taxes | |||
|
Condensed Balance Sheets (USD $)
|
Mar. 31, 2013
|
Dec. 31, 2012
|
|---|---|---|
| Current assets | ||
| Cash | ||
| Total current assets | ||
| Total assets | ||
| Current liabilities | ||
| Accounts payable | 3,446 | 3,351 |
| Related party loans | 2,836 | 1,706 |
| Total current liabilities | 6,282 | 5,057 |
| Stockholders' (deficit) | ||
| Common stock, no par value; 250,000,000 shares authorized; and 54,521,000 issued and outstanding | 81,781 | 81,781 |
| Deficit accumulated during development stage | (88,063) | (86,838) |
| Total stockholders' (deficit) | (6,282) | (5,057) |
| Total liabilities and stockholders' (deficit) |